ECS Botanics Holdings Ltd. reported that it has concluded its first shipment of dried cannabis flower to NUBU. As previously announced ECS entered into a four-year supply agreement with Nubu. This shipment follows the successful registration of ECS Botanics strains, cultivated at the Company's cultivation facility in Victoria.

The strains are registered as flower for inhalation, the first imported cannabis flower registered for inhalation in New Zealand. NUBU's enviable distribution network spans the length and breadth of New Zealand - encompassing every pharmacy in the country and all major specialty clinics. The company is also the leading voice in dried flower education, to prescribers and pharmacists, via NUBU's Medical Director, Kady Chemal BPharm (Hons).

ECS anticipates that New Zealand will grow to become a strong market for ECS over the 2022/23 financial year, as the quality and competitive pricing of the Company's GMP-certified naturally, and organically grown products become increasingly in demand. The company is currently progressing product registration in Poland and Germany.